Phase 1 Leptomeningeal Metastases Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
Leptomeningeal Metastases
Memorial Sloan Kettering Cancer Center35 enrolled7 locationsNCT05184816
Recruiting
Phase 1Phase 2
Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
Leptomeningeal Metastases
Guangzhou Medical University34 enrolled1 locationNCT06462092